Fragile X Syndrome, Diagnostic

Alphabetical Test listing

Fragile X Syndrome, Diagnostic-15274

  
Fragile X Syndrome, Diagnostic
  
15274
  
LAB15274
  
FRAXDI
  
Fragile X Testing
Fragile X-associated primary ovarian insufficiency (FXPOI)
Fragile X-associated tremor and ataxia syndrome (FXTAS)
FMR1
  

This test is used for diagnostic testing for unexplained intellectual disabilities, developmental delay, or autism; women with primary ovarian insufficiency or failure, premature menopause, or infertility associated with elevated FSH levels before the age of 40 with no known cause; individuals with late onset intention tremor and/or cerebellar ataxia of unknown origin; and FMR1.

  
EDTA whole blood
  
  
8.5 mL
  
3.0 mL
  

Immediately following collection, mix by inverting 8 - 10 times to prevent clotting

  

Do not spin

  

Lavender (EDTA), 4mL x 3

or

Lavender (EDTA), 10mL

  
ACD whole blood
  

Yellow ACD (A or B)

  

  

Yellow ACD (A or B)

  

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

  

Ambient (preferred) - 14 days

Refrigerated - 30 days

Frozen - NO

  

Frozen or hemolyzed specimens

  
LabCorp RPT (481701); R-LC
  
8 - 14 days
In some cases, additional time may be required for confirmatory or reflex tests.
  

Polymerase chain reaction (PCR) followed by capillary electrophoresis, methylation PCR analysis and reflex to AGG interruption analysis when appropriate

  

See report

  
81243; 81244
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Molecular Medicare Billing Request

  
05/23/2024
  
07/17/2024
  
05/23/2024